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ARTICLE
Filamin A Is Mutated in X-Linked Chronic Idiopathic Intestinal
Pseudo-Obstruction with Central Nervous System Involvement
Annagiusi Gargiulo,* Renata Auricchio,* Maria Vittoria Barone, Gabriella Cotugno, William Reardon,
Peter J. Milla, Andrea Ballabio, Alfredo Ciccodicola, and Alberto Auricchio
We have previously reported that an X-linked recessive form of chronic idiopathic intestinal pseudo-obstruction (CIIPX)
maps to Xq28. To select candidate genes for the disease, we analyzed the expression in murine fetal brain and intestine
of 56 genes from the critical region. We selected and sequenced seven genes and found that one affected male from a
large CIIPX-affected kindred bears a 2-bp deletion in exon 2 of the FLNA gene that is present at the heterozygous state
in the carrier females of the family. The frameshift mutation is located between two close methionines at the filamin N
terminus and is predicted to produce a protein truncated shortly after the first predicted methionine. Loss-of-function
FLNA mutations have been associated with X-linked dominant nodular ventricular heterotopia (PVNH), a central nervous
system (CNS) migration defect that presents with seizures in females and lethality in males. Notably, the affected male
bearing the FLNA deletion had signs of CNS involvement and potentially has PVNH. To understand how the severe
frameshift mutation we found can explain the CIIPX phenotype and its X-linked recessive inheritance, we transiently
expressed both the wild- type and mutant filamin in cell culture and found that filamin translation can start from either
of the two initial methionines in these conditions. Therefore, translation of a normal shorter filamin can occur in vitro
from the second methionine downstream of the 2-bp insertion we found. We confirmed this, demonstrating that the
filamin protein is present in the patient’s lymphoblastoid cell line that shows abnormal cytoskeletal actin organization
compared with normal lymphoblasts. We conclude that the filamin N terminal region between the initial two methionines
is crucial for proper enteric neuron development.
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Chronic idiopathic intestinal pseudo-obstruction (CIIP
[MIM %300048]) is a clinical syndrome caused by a het-
erogeneous group of enteric neuromuscular diseases that
result in a severe abnormality of gastrointestinal motility.1
CIIP may present at any age and is diagnosed by radio-
logical, surgical, or manometric evidence of abnormal
bowel motility causing intestinal obstruction in the ab-
sence of any mechanical occlusion.1 CIIP is an uncom-
mon, often fatal, syndrome in infancy, which may occur
because of primary intrinsic visceral neuromuscular dis-
orders or secondary to a variety of conditions, such as drug
toxicity, ischemia, inflammatory or autoimmune diseases,
myopathies, or viral infections (e.g., Epstein-Barr or cyto-
megalovirus [CMV]).1 Primary forms of CIIP are neuro-
genic (28%), myopathic (36%), or unclassifiable (36%).2
Neuropathic abnormalities of enteric innervation cause
neurogenic CIIP and may be quantitative (hypo-, hyper-,
and aganglionosis) or qualitative in nature.2 In Hirsch-
sprung disease (HSCR [MIM #142623]), the most common
neuronal CIIP, lack of migration of enteric ganglion cells
during development results in aganglionosis along gastro-
intestinal segments of variable length.2 In other cases, mi-
gration of enteric neurons is not affected, but enteric gan-
glia and nerve fibers show qualitative abnormalities, sug-
gesting the presence of a differentiation defect. This may
be the case for the patients described by Tanner3—affected
by a short intestine, malrotation, and hypertrophic pyloric
stenosis—who were reported to have absence of argyro-
philic neurons in the myenteric plexus.3 The condition
was thought to be inherited as an autosomal recessive
trait.3 More recently, we reported an Italian family with
10 affected males in 4 generations, all related through
healthy females; of the 10, 9 died in the first months of
life. Two affected subjects (IV-1 and IV-5) in the last gen-
eration (fig. 1A) had severe CIIP associated with a short
small intestine, malrotation, and hypertrophic pyloric ste-
nosis.4 Subject IV-1 survived repeated surgery and is still
alive. Histological analysis of full-thickness ileal and co-
lonic biopsies of samples from the two subjects evidenced
abnormal neurons in the myenteric and submucosal plex-
uses.4 Like the patients described by Tanner et al.,3 there
were abnormalities of argyrophilic neurons. In our study
family, the condition appeared to be inherited with a clear
X-linked recessive pattern—that is, X-linked chronic id-
iopathic intestinal pseudo-obstruction (CIIPX)—and we
mapped the disease locus to Xq28 between DXS15 and
DXYS154.4 There was an additional report by FitzPatrick
et al.5 about neurogenic CIIP with patent ductus arteriosus
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Figure 1. A, Pedigree of the CIIPX-affected family. B, Chromatogram showing FLNA exon 2 sequence around c.65-66delAC. Top, Sequence
of the obligate carriers (I-1, II-1, II-5, III-2, and III-6,). Middle, Sequence of healthy male (III-1). Bottom, Sequence of the affected
male (IV-1). The arrow indicates c.65-66delAC.
and large platelet thrombocytopenia, apparently inherited
in an X-linked recessive manner. By April 2003, 63 genes
were annotated in the CIIPX critical region (Human Ge-
nome Browser Gateway). We analyzed their expression in
fetal murine gut and brain, to select candidate CIIPX
genes, and we found a frameshift mutation in the filamin
A gene (FLNA [MIM 300017]) that was associated with
CIIPX in the Italian kindred.
Material and Methods
Clinical History
The index patient (IV-1), second cousin to subject IV-5, is a male
and the first offspring of healthy, nonconsanguineous parents
(fig. 1A). He was born at term after an uneventful pregnancy. On
the 3rd d of life, he presented with bilious vomiting, and lapar-
atomy showed a short small bowel with intestinal malrotation,
pyloric hypertrophy, and an ileal volvulus. Fifteen days later, he
required additional surgery for intestinal obstruction, and an il-
eostomy was raised. Histological examination of full-thickness
ileal and colonic biopsies showed abnormal argyrophilic neurons
in the myenteric plexus, as well as nerve fibers in the lamina
propria in the colon.4 Findings similar to the myenteric plexus
were present in the submucosal plexus. At age 3 mo, continuity
of his bowel was restored with an ileoileal anastomosis, but the
bowel once again became obstructed. Manometric studies sug-
gested a neuropathic disorder of his gut. A further ileostomy was
raised, and full-thickness material was taken for further histology.
At age 3 years, a Lester-type ileorectal anastomosis was performed
to restore bowel continuity. In addition to the severe CIIP, by age
7 years, an asymmetrical spastic diplegia with impairment of fine
finger movements also became apparent. Magnetic resonance im-
aging (MRI) of his brain showed an abnormal intermediate signal
in the peritrigonal white matter. The patient and two carrier fe-
males in the family declined to undergo additional brain MRI
after the identification of the FLNA mutation. The patient re-
quired lengthening operations for both Achilles tendons. He also
had seizures: the first time after surgery during his 1st mo of life,
then again at ages 8 and 18 years. Since the last episode, he has
received carbamazepine treatment. He continues to require sup-
plemental parenteral nutrition to maintain good health.
The second patient (IV-5) was a male, the third offspring of
healthy, unrelated parents (fig. 1A). His older brother and sister
have no gastrointestinal disorders and are completely well. He
was born at term, weighed 4.2 kg, and measured 52 cm in length.
On his 1st d of life, he had abdominal distension and bilious
vomiting. Laparotomy demonstrated a small-intestinal malrota-
tion with CIIP. Because of ongoing subocclusive symptoms, two
intestinal resections were performed during the following weeks.
He required total parenteral nutrition and an additional operation
with ileoileal anastomosis. Intestinal histology of the ileum showed
abnormalities of the myenteric and submucosal neurons similar
to those of subject IV-1. Subject IV-5 died shortly after surgery,
at age 8 mo.
Genomic DNA Extraction and PCR Amplification
and Sequencing
Genomic DNA was isolated from peripheral–whole-blood lym-
phocytes and from paraffin-embedded sections by use of stan-
dard protocols (Qiagen Italy) or as described elsewhere.4 The com-
plete coding sequence of seven genes selected for direct sequenc-
ing, including the exon-intron boundaries, was amplified by PCR
with Taq Gold DNA Polymerase (Roche). These genes are (from
X chromosome centromere to telomere): ZNF275, ATP2B3 (MIM
*300014), DUSP9 (MIM *300134), SLC6A8 (MIM *300036),
ABCD1 (MIM *300371), L1CAM (MIM *308840), and FLNA. PCR
was performed as follows: 35 cycles with 50 ng of genomic DNA
at 94C for 1 min, at the appropriate primer annealing temper-
ature for 1 min, and at 72C for 1 min. Primers and reaction
conditions for PCR amplification are available on request.
Amplicons were screened for mutations by direct sequencing
with an ABI PRISM Big Dye terminator cycle sequencing kit, and
the reactions were analyzed with an ABI PRISM 3100 genetic an-
alyzer (Applied Biosystems). The sequenced exon and intron-
exon boundaries were compared with consensus sequences ob-
tained from the National Center for Biotechnology Information
Database with use of standard software for DNA sequencing anal-
ysis (Autoassembler v. 2.1 [Applied Biosystems]). Sixty-six females
and 32 males from the general Italian population were used as
controls, for a total of 164 X chromosomes.
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Figure 2. Effect of c.65-66delAC on filamin A translation. A, Sequence of the filamin A NH2 terminus. Black letters indicate wild-type
protein sequence; gray letters indicate predicted amino acid changes caused by c.65-66delAC; the asterisk (*) indicates a stop codon;
“Met1” and “Met2” indicate the first and second filamin A methionines, respectively. B, Schematic representation of plasmids 1 and 2
expressing filamin A NH2 terminus (amino acid residues 1–124) fused to the HA under the control of the CMV promoter. The line between
Met1 and Met2 in plasmid 2 indicates the position of c.65-66delAC. C, Western blot analysis of FLNA expression in HEK 293 cells
transfected with plasmids 1 and 2 and in an untransfected control. Protein molecular weight is shown on the left. The primary antibodies
used are shown on the right.
RT-PCR Analysis of Gene Expression from the CIIPX Critical
Region
Total RNA from C57BL/6 mice (Harlan Italy), from embryonic
day–18 (E18) mouse brain or gut, from 5-wk-old mouse gut, and
from V-1 individual lymphoblastoid cells was extracted using the
Trizol reagent (Invitrogen Italy) according to the manufacturer’s
instructions. After DNAse treatment, 5 mg of total RNA was used
as a template for cDNA synthesis, with use of random primers
and SuperScript III (Invitrogen Italy). Subsequently, PCR ampli-
fication was performed using oligonucleotides specific for each
of the 63 genes included in the CIIPX critical region and was
designed in the region of homology between human and murine
RNAs with use of the Oligo 4.0 software (National Biosciences).
PCR was performed using Taq Gold DNA polymerase (Roche),
with 35 cycles at 94C for 1 min, at the appropriate primer an-
nealing temperature for 1 min, and at 72C for 1 min. Primer
sequences and reaction conditions for each gene are available on
request.
Generation of the Plasmid Constructs Expressing Filamin A
NH2 Terminus
We generated two plasmids that express the first N-terminal 124
aa of FLNA by fusing to a hemoagglutinin tag (HA) under the
transcriptional control of the ubiquitous CMV promoter. In plas-
mid 1, the wild-type FLNA sequence was included, whereas, in
plasmid 2, the FLNA sequence corresponding to c.65-66delACwas
introduced. To do so, FLNA exon 2 sequence from the initial ATG
codon to genome position 3688 was amplified from control and
the patient’s genomic DNA, with use of primers NotI, 5′-ATG AGT
AGC TCC CAC TCT CGG GCG GGC CAG-3′, and BamHI-TTA-
HA epitope tag, 5′-GAT GGA CAC CAG TTT GAT GCT CTC GCG
GT-3′. The amplification was performed with Pfu DNA Polymerase
(Promega Italy). The PCR product was inserted into PCR 2.1-
TOPO plasmid (Invitrogen) and then was digested with NotI and
BamHI restriction enzymes. The corresponding fragments from
control and patient were then cloned into pAAV2.1-CMV-EGFP6
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Figure 3. Western blot analysis of filamin A expression in patient
IV-1 lymphoblasts. The amount of total protein loaded for each
individual is shown above the lanes. Protein molecular weight is
shown on the left. The primary antibodies used are shown on the
right.
by removing the EGFP-coding sequence, to obtain plasmid 1 and
plasmid 2, respectively.
Transfection of HEK 293 Cells with Constructs Expressing
Filamin A and Western Blot Analysis
Human embryonic kidney (HEK) 293 cells were plated in 6-well
plates containing cells/well. After 24 h, the cells were53# 10
separately transfected with 2 mg/well of plasmid 1 and plasmid 2
with use of FUGENE 6 (Roche), according to the manufacturer’s
instruction. Transfection with pAAV2.1-CMV-EGFP was used as a
control. After 48 h, proteins from transfected cells were extracted
with Lysis buffer (50 mM NaCl, 25 mM Tris [pH 8.0], 0.5% NP40,
0.1% SDS, 1 mM protease inhibitors [Roche], and 1 mM phenyl-
methylsulphonyl fluoride) and were kept on ice for 20 min. Sam-
ples were spun at 13,000 rpm for 20 min, and supernatants were
collected. Protein concentrations were determined with the Bio-
Rad dye protein assay. The proteins were denatured by heating
at 98C for 3 min and were separated on a 16% SDS-polyacryl-
amide gel electrophoresis with 4% stacking gel in 1# Tris-glycine
buffer (0.025 M Tris, 0.192 M glycine, and 0.1% SDS [pH 8.3]) in
a miniprotean cell (Bio-Rad) at 130 volts for 2 h. The separated
proteins were electrotransferred onto a polyvinylidene fluoride
(PVDF) membrane with transfer buffer (25 mM Tris base, 0.2 M
glycine, and 20% methanol [pH 8.5]) in a minitransfer cell (Bio-
Rad) at 100 volts at 4C for 1 h. Membranes were incubated at
room temperature for 1.5 h in blocking buffer containing 1# TBS
and 0.05% Tween 20 with 5% dried nonfat milk and then were
probed with an anti-HA antibody (Sigma-Aldrich) for 2 h at room
temperature. This was followed by incubation with a peroxidase-
conjugated secondary anti-rabbit IgG for 1 h at room temperature.
Signals were detected by chemoluminescence with the Pico En-
hanced Chemiluminescence Kit (Pierce Chemical). A prestained
molecular-weight ladder (Fermentas) was used to determine pro-
tein size.
Western Blot Analysis of Filamin A Expression in Patient
Lymphoblasts
Lymphoblasts from patient IV-1 and from two control individuals
were grown in Roswell Park Memorial Institute PMI 1640 plus
medium with 20% fetal bovine serum (FBS) in 5% CO2 at 37C,
were harvested, precipitated, and lysed with Lysis buffer (50 mM
NaCl, 25 mM Tris [pH 8.0], 0.5% NP40, 0.1% SDS, 1 mM protease
inhibitors [Roche], and 1 mM PMSF) on ice for 20 min. Samples
were spun at 13,000 rpm for 20 min, and supernatants were col-
lected. Protein concentrations were determined with the Bio-Rad
dye protein assay. The proteins were denatured by heating to 98C
for 3 min and then were separated on a 7% SDS-polyacrylamide
gel electrophoresis with 4% stacking gel in 1# Tris-glycine buffer
(0.025 M Tris, 0.192 M glycine, and 0.1% SDS [pH 8.3]) in a
miniprotean cell (Bio-Rad). The separated proteins were electro-
transferred onto PVDF membrane with a transfer buffer (25 mM
Tris base, 0.2 M glycine, and 20% methanol [pH 8.5]) in a mini-
transfer cell (Bio-Rad) at 4C for 1 h. Membranes were incubated
overnight in blocking buffer containing 1# TBS and 0.1% Tween
20 with 5% dried nonfat milk and then were probed with anti–
filamin A antibody (Cell Signaling) for 3 h at room temperature.
This was followed by incubation with the peroxidase-conjugated
secondary anti-rabbit IgG for 1 h at room temperature. Signals
were detected by chemoluminescence through use of the Pico En-
hanced Chemiluminescence Kit (Pierce Chemical). A prestained
molecular-weight ladder (Fermentas) was used to determine pro-
tein size.
Immunofluorescence Analyses
Lymphoblasts were obtained from two unaffected subjects and
from patient IV-1. Cells were cultured in serum-free RPMI 1640
medium plus 20% FBS (Invitrogen). Cells (∼3,000) were centri-
fuged with Cytospin Centrifuge for Cells Suspensions (Shandon
Cytospin 3 Cytocentrifuge [Global Medical Instrumentation]) at
800 rpm for 3 min and were transferred to the corresponding
glass slides. Cells were fixed with 3% paraformaldehyde (Sigma)
for 10 min at room temperature. After one wash with 1# PBS
(Invitrogen), Triton 0.2% (Bio-Rad) was applied to the slides,
which were then incubated at room temperature for 5 min. After
another wash with 1# PBS, slides were incubated for 45 min in
the dark with phalloidin-Texred (Sigma) (diluted 1:500 in 1#
PBS), with mouse antibodies directed to g-tubulin (Sigma) (di-
luted 1:50 in 1# PBS), or with rabbit antibodies to filamin A (Cell
Signalling) (diluted 1:250 in 1# PBS). Fluorochromes can directly
bind the phalloidin, which in turn links F-actin, revealing F-actin
without antibodies. Secondary anti-mouse and anti-rabbit anti-
bodies (Invitrogen) conjugated to rhodamine were used at con-
centrations of 1:1000 and 1:200 dilutions, respectively, in 1#
PBS. Slides were covered with Mowiol gel (Calbiochem) and then
were analyzed by fluorescence microscopy (Laser Scanner Mi-
croscopy 510 Zeiss).
Results
Mutation of FLNA in CIIPX
To identify the gene mutated in CIIPX, we analyzed, by
reverse transcriptase, the expression pattern of the genes
from the CIIPX critical region on Xq28 in c57/BL6 fetal
(E18) brain and gut. Of the 63 genes located in the CIIPX
critical region, 56 are homologous in mouse and human
and therefore were analyzed. We found that 7 of 56 genes
are expressed only in intestine, 13 are expressed only in
brain, and 28 are expressed in both intestine and brain.
Eight genes are not expressed in either tissue but are ex-
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Figure 4. Actin organization and g-tubulin distribution in patient IV-1 lymphoblasts. A, Actin immunofluorescence with phalloidin-
Texred in patient IV-1 and control lymphoblasts. The white arrows indicate the phalloidin spots, which are more abundant in patient
IV-1 than in control lymphoblasts. B, Staining for actin with phalloidin-Texred (green staining) and for g-tubulin (red staining) in patient
IV-1 and control lymphoblasts. The merged image on the right shows that the phalloidin spots are on the centrosomal side of patient
IV-1 lymphoblasts.
pressed in lymphoblastoid cell lines (data not shown). We
selected seven genes (ZNF275, ATP2B3, DUSP9, SLC6A8,
ABCD1, L1CAM, and FLNA) from those expressed in both
tissues for direct sequencing analysis of exon and intron-
exon boundaries. ABCD1, L1CAM, SLC6A8, and FLNA
were selected as candidate genes because of their involve-
ment in already-known inherited disorders of the nervous
system7–10; ATP2B3 is a plasma-membrane protein possibly
involved in the regulation of physiological ions homeo-
stasis11; DUSP9 was selected because of its protein’s inter-
actions with members of the extracellular signal-regulated
kinase family of mitogen-activated protein kinases, its pos-
sible involvement in regulation of gene expression in neu-
rons of neuroenteric system, and its contribution to pain
caused by inflammation12; finally, ZNF275, because of its
protein’s high similarity to a Zinc-finger protein, was se-
lected as a possible uncharacterized novel putative tran-
scriptional activator.13
We found that the index patient (IV-1) bears a 2-bp
deletion in exon 2 of FLNA (c.65-66delAC). Segregation
analysis of the FLNA mutation confirms that all obligate
carriers, by pedigree or established by linkage analysis,4
are heterozygous for the 2-bp deletion (fig. 1B). The mu-
tation is absent in 164 control X chromosomes.
Recently, a wide spectrum of developmental anomalies
has been shown to be caused by mutations in FLNA.14 Null
mutations in the FLNA gene result in bilateral periventri-
cular nodular heterotopia (PVNH [MIM #300049]), an X-
linked dominant neuronal migration disorder clinically
characterized by seizures.15 The association between a po-
tential severe loss-of-function FLNA mutation and an X-
linked recessive disease involving enteric neuron develop-
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Figure 5. Actin organization and filamin A distribution in patient IV-1 lymphoblasts. Staining for actin with phalloidin-Texred (green
staining) and for filamin A (red staining) in patient IV-1 and control lymphoblasts. The merged image on the right shows that the actin
organization and filamin A distribution in the cells are similar.
ment prompted us to investigate the effect of FLNA c.65-
66delAC at the protein level.
ATG Downstream of FLNA c.65-66delAC Allows Production
of a Shorter Filamin A Form
The c.65-66delAC deletion found in patients with CIIPX
is predicted to cause a frameshift and a premature stop
codon at filamin A amino acid position 103 (fig. 2A). The
predicted mutant protein retains the initial 22 aa identical
to wild-type filamin A, followed by 81 different aa before
a premature stop codon. This is the most severe FLNA loss-
of-function mutation described to date,16 predicted to
cause lethality in males and PVNH phenotypes in females.
Interestingly, the c.65-66delAC deletion is located 22 co-
dons downstream of the initial FLNA ATG (Met1) (fig. 2A)
and 5 codons upstream of a second ATG (Met2) (fig. 2A).
If filamin A translation occurs from either methionine and
results in the synthesis of two proteins differing in 27 aa
at the NH2 terminus, the c.65-66delAC deletion would
affect only the translation of the longer form of filamin
A. To determine whether this is the case, we transiently
transfected HEK 293 cells with two different eukaryotic ex-
pression plasmids containing the CMV promoter, as shown
in figure 2B. In both plasmids, the FLNA-coding sequence
from the first methionine to amino acid residue 124 (cor-
responding to the end of exon 2) was fused to an HA
peptide at its 3′ end, resulting in peptides of 124 aa of
predicted length if translation occurs from Met1 or of 96
aa if it occurs from Met2. Whereas the wild-type FLNA
sequence was included in plasmid 1, that bearing the c.65-
66delAC deletion was present in plasmid 2. As shown in
figure 2C, cells transfected with plasmid 1 express both
filamin A forms, whereas those transfected with plasmid
2 express only the shorter form of the protein, albeit at
lower levels, possibly because of nonsense-mediated de-
cay. This suggests that (1) filamin A translation can start
from either of its two initial methionines, (2) translation
of the shorter filamin A form alone occurs because of
the c.65-66delAC deletion. To confirm this, we analyzed
endogenous filamin A expression in control and patient
IV-1 lymphoblasts. Western blot with anti–filamin A an-
tibodies shows that filamin A expression in the patient’s
lymphoblasts is similar to expression in control lympho-
blasts (fig. 3A). Although, because of filamin A’s high mo-
lecular weight (280 kDa), we cannot discriminate whether
the protein present in the patient’s lymphoblasts is of
lower molecular weight than that in control lymphoblasts,
these data confirm that c.65-66delAC results in filamin A
translation despite the early frameshift. Finally, we inves-
tigated the impact of c.65-66delAC on cytoskeletal orga-
nization in the patient’s lymphoblasts. Whereas actin im-
munofluorescence staining with phalloidin-Texred is pre-
dominantly diffused in the cytoplasm in lymphoblasts
from healthy control individuals, in the cells derived from
the patient, actin appears mainly concentrated in large
dots localized on the centrosome side of the cells (fig. 4;
the percentage of cells containing phalloidin dots in pa-
tient vs. control lymphoblasts was 78% vs. 9.4%). We con-
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firmed, by immunofluorescence, the presence of filamin
A in the patient’s lymphoblasts and that it has a distri-
bution similar to that of actin (fig. 5).
We additionally screened a series for but did not find
any FLNA mutations in 12 individuals (8 unrelated spo-
radic and 4 familial cases, 8 males and 4 females, including
1 of the affected males described by FitzPatrick et al.5)
affected with isolated non-HSCR CIIPX. In addition, the
observed higher penetrance of HSCR in males than in
females17 prompted us to hypothesize that CIIPX might
represent an additional susceptibility locus for HSCR. We
therefore sequenced the FLNA region containing the two
adjacent ATG codons in 37 unrelated patients affected
with HSCR (27 males and 10 females), but we did not find
any sequence variants.
Discussion
In this article, we show that CIIPX with CNS involvement
is associated with a 2-bp deletion in the FLNA gene. This
expands the wide spectrum of developmental anomalies
caused by FLNA mutations. The FLNA loss-of-function mu-
tations found in PVNH are embryonic lethal in males,18
although there are reports of males with PVNH who har-
bor hypomorphic FLNA mutations.16 FLNA-targeted dis-
ruption in mice causes male embryonic lethality, cardiac
malformation, and midline skeletal defects.19 Interestingly,
Hehr et al.20 described a male with PVNH without epilepsy
but with severe constipation and facial dysmorphisms
who bears an FLNA splice-site mutation resulting in the
generation of both normal and aberrant FLNA mRNA. The
male patient in our CIIPX-affected family had seizures and
potentially has PVNH. Different from the male with PVNH
and constipation described by Hehr and colleagues,20 the
CIIPX phenotype in our family is most distinguished by
severe CIIP, present at birth, that is lethal unless promptly
corrected by surgery.
FLNA encodes for a large cytoskeletal protein (2,639 aa)
that cross-links the actin cytoskeleton into orthogonal net-
works and modulates the cellular response to chemical and
mechanical environmental factors by regulating changes in
their shape and motility.21 In mammals, there are three
highly homologous filamins: filamin A, B, and C. An actin-
binding domain is located at the NH2 terminus of these
proteins and is composed of two calponin homology do-
mains: CH1 and CH2. The remainder of the filamin mol-
ecule is composed of 24 filamin repeats that are predicted
to adopt structurally homologous b-sheet configurations
despite significant divergence at the protein level.22 The
chain of repeats is interrupted by two hinge regions that
are proposed to confer flexibility to the Y-shaped filamin
dimer. Homodimerization is mediated by the most C-ter-
minal repeat 24 and possibly by other protein domains.
We show that, rather than causing a early frameshift, the
c.65-66delAC deletion found in the CIIPX-affected patient
results in translation of a shorter filamin A from the sec-
ond ATG. We initially observed this after western blot
analysis of lysates from cells transfected with plasmids
expressing either the wild-type or the c.65-66delAC cDNA,
and we then confirmed the presence of detectable filamin
A in the patient’s lymphoblasts by both western blot and
immunofluorescence analyses. Interestingly, the presence
of the mutant filamin A results in peculiar cytoskeletal
organization, reflected by a larger amount of phalloidin
dots in the patient’s than in the control lymphoblasts,
which are located on the centrosomal side of the cells.
Others have described this large actin dots as “constriction
rings.”23 Since cell motility is based on the periodic oscil-
latory activity of the actin system in association with ring
formation and movement across the cell,23 this ring can
contribute to an abnormally polarized cell-surface motility.
This partial FLNA loss of function may explain the re-
cessive CIIPX inheritance in our family. What remains to
be elucidated is why this is associated with severe CIIP
rather than with a classic PVNH phenotype. In CIIPX,
abnormal neurons are present in the myenteric and sub-
mucosal plexuses, whereas, in classic PVNH, normally dif-
ferentiated cortical neurons fail to migrate properly. The
association between frameshift and missense heterozygous
FLNA mutations with PVNH but not with CIIP may sug-
gest that filamin A dose impacts more severely on cortical
neuron migration than on enteric-neuron development.
Conversely, since we show that FLNA c.65-66delAC is as-
sociated with CIIPX, it is possible that the first 27 FLNA
aa residues between Met1 and Met2, adjacent to filamin
A actin-binding site21 and absent in filamin A shorter
form, are crucial for proper enteric neuron structure and
function.
In conclusion, we show that FLNA c.65-66delAC causes
CIIPX with CNS involvement in our family and results in
the synthesis of a shorter filamin A form responsible for
cytoskeletal abnormalities, which suggests a crucial role
for FLNA in enteric-neuron structure and function.
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Web Resources
The URLs for data presented herein are as follows:
Human Genome Browser Gateway, http://genome.ucsc.edu/
cgi-bin/hgGateway (for the CIIPX critical region)
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for CIIP, HSCR, FLNA, ATP2B3, DUSP9,
SLC6A8, ABCD1, L1CAM, and PVNH)
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